Sie suchten nach: gestational (Englisch - Maltesisch)

gestational age (sga)
tat- tqala (sga)

small for gestational age
daqs żgħir għaż-żmien tat-tqala

gestational age of less than 34 weeks.
ġestazzjonali ta ’ inqas minn 34 ġimgħa

gestational age below 24 or over 33 completed weeks
tqala ta’ inqas minn 24 ġimgħa jew f’dik ta’ iktar minn 33 ġimgħa magħluqa

children/adolescents born small for gestational age (sga)
tfal/adolexxenti li twieldu żgħar għaż-żmien tat-tqala (sga)

preterm infants born after at least 24 weeks of gestational age
trabi li jitwieldu qabel iż-żmien wara tal-inqas 24 ġimgħa ta’ tqala

a gestational age from 24 until 33 completed weeks a normal foetal heart rate
tqala minn 24 sa 33 ġimgħa magħluqa rata tal-qalb tal-fetu normali

dosing recommendations are not available for neonates with a gestational age < 37 weeks.
m’hemmx doża rrakkomandata għal trabi għandhom jitwieldu ta’ < 37 ġimgħa.

long-term treatment of children with growth disturbance due to born small for gestational age
kura fit-tul ta’ tfal b’disturb tat-tkabbir minħabba li twieldu żgħar għaż-żmien tat-tqala

growth disturbance in short children/adolescents born small for gestational age (sga)
disturb tat-tkabbir fi tfal qosra/adolexxenti li twieldu żgħar għaż-żmien tat-tqala (small for gestational age - sga)

the clearance of both enantiomers increases with gestational age, at least in the range of 24 to 28 weeks.
it-tneħħija taż-żewġ enantjomeri tiżdied mal-età tal-ġestazzjoni mill-inqas fil-medda ta’ 24 sa 28 ġimgħa.

it is essential for patients with pre-existing or gestational diabetes to maintain good metabolic control throughout pregnancy.
huwa essenzjali li l-pazjenti li kellhom id-dijabete qabel jew għandhom id-dijabete waqt it-tqala jżommu kontroll metaboliku tajjeb tul it-tqala kollha.

- with growth disturbance in short children/ adolescents born small for gestational age (sga),
- b’ disturb tat- tkabbir (devjazzjoni standard ta ’ l- iskorjar/ standard deviation score (sds) kurrenti

in a clinical study, 670 pre-term infants from 27 to 36 weeks of gestational age were administered rotarix and 339 received placebo.
f’studju kliniku, rotarix ingħata lil 670 tarbija mwielda qabel iż-żmien, minn 27 sa 36 ġimgħa ta’ tqala waqt li 339 trabi rċievew il-plaċebo.

mean clearance in premature infants (gestational age approximately 26 weeks) is approximately 5-fold greater than in adults.
il- medja tat - tneħħija fi trabi prematuri (età tal- ġestazzjoni ta ’ madwar 26 ġimgħa) hija madwar 5 darbiet aktar milli fl- adulti.

brinzolamide has not been studied in pre-term infants (less than 36 weeks gestational age) or those less than 1 week of age.
brinzolamide ma ġiex studjat fi trabi li twieldu qabel iż-żmien (inqas minn 36 gimgħa tqala) jew f’dawk li kellhom inqas minn ġimgħa.

it is essential to maintain good control of the insulin-treated (insulin-dependent or gestational diabetes) patient throughout pregnancy.
huwa essenzjali li jinżamm kontroll tajjeb tal-pazjenti kkurati bl-insulina (dawk li jiddependu fuq l- insulina jew id-dijabete ta' waqt it-tqala) matul it-tqala.

this was a double-blind, placebo-controlled, randomised study in pre-term or term neonates (gestational age 36–42 weeks) with pphn.
dan kien studju double-blind, ikkontrollat bil-plaċebo u randomised fi trabi tat-twelid li twieldu qabel iż-żmien u trabi li twieldu fi żmienhom (età ta’ ġestazzjoni ta’ 36-42 ġimgħa) b’pphn.